| abstract |
Novel peptide mimetic compounds are provided which have useful activity as inhibitors of platelet aggregation. These compounds have the chemical structure <IMAGE> wherein x=4 to 8, y=0 to 4, W=CH2-CH2 or CH=CH, Z=H, COOH, CONH2, CH2OH, CO2R, CH2OR or C1-6 alkyl, R=C1-6 alkyl, Ar=a nitrogen-containing heterocyclic group, and Asp=aspartic acid residue. |